[1]
“Alzheimer’s dementia: budget impact and cost-utility analysis of a combination treatment with a cholinesterase inhibitor and memantine in Switzerland”, Swiss Med Wkly, vol. 142, no. 4748, p. w13676, Nov. 2012, doi: 10.4414/smw.2012.13676.